Vancomycin Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-596

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Vancomycin Hydrochloride (NDC 68083-596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vancomycin-carton-1-25g (Carton Label 1 25g)

Vancomycin-carton-1-25g (Carton Label 1 25g)
This text provides information about Vancomycin Hydrochloride for Injection, USP. It includes details such as dosage, reconstitution instructions, storage conditions, manufacturer information, and precautions. The medication is supplied in 1.25g single-dose vials and is intended for intravenous use. It emphasizes the importance of reading the package insert before use and highlights the need for further dilution after reconstitution.*
FDA Label Image

Vancomycin-carton-1-5g (Carton Label 1 5g)

Vancomycin-carton-1-5g (Carton Label 1 5g)
This is information about a medication containing Vancomycin Hydrochloride. It provides details on dosage, administration, storage, and precautions. The text includes instructions to reconstitute the contents with sterile water for injection and emphasizes the necessity to dilute the solution further after reconstitution. It also specifies the storage conditions and shelf-life of the medication.*
FDA Label Image

Vancomycin-carton-750mg (Carton Label 750 mg)

Vancomycin-carton-750mg (Carton Label 750 mg)
Vancomycin Hydrochloride for Injection, USP is a sterile powder available in 10 x 750 mg single-dose vials. This medication is intended for intravenous use and must be further diluted after reconstitution. Each vial contains Vancomycin hydrochloride, USP equivalent to 750 mg. The usual adult dosage can be found in the package insert along with precautions and directions for use. Prior to reconstitution, it should be stored at 2°C to 25°C, and after reconstitution, it can be refrigerated for up to 14 days without significant loss of potency. This product is manufactured by Gland Pharma Limited in India.*
FDA Label Image

Vancomycin-hydrochloride-spl-structure (Vancomycin Hydrochloride Spl Structure)

FDA Label Image

Vancomycin-vial-1-25g (Vancomycin Vial 1 25g)

FDA Label Image

Vancomycin-vial-1-5g (Vancomycin Vial 1 5g)

Vancomycin-vial-1-5g (Vancomycin Vial 1 5g)
This is a description of a single-dose vial of Vancomycin Hydrochloride for Injection, USP. It is intended for intravenous use and must be further diluted after reconstitution. The product is in a sterile powder form and comes with an NDC code 68083-597-01. The text also includes some technical information and warnings related to the product's usage.*
FDA Label Image

Vancomycin-vial-750mg (Vancomycin Vial 750mg)

Vancomycin-vial-750mg (Vancomycin Vial 750mg)
This is a product label for a pharmaceutical item, potentially a vial containing 750 mg of medication for intravenous use. It is manufactured by Gland Pharma Limited in India. The text also includes details such as manufacturing location and authorization numbers. The product must be further diluted after reconstitution. If more information is needed, referring to the package insert is recommended.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.